过去10年心肺移植:单中心经验与当代概念更新
该单中心回顾性研究分析了2008-2018年49例心肺移植受者,比较2008-2015年(Era I,n=30)与2016-2018年(Era II,n=19)两个队列。Era II的肺分配评分显著更高(51.1±19.8 vs 41.6±19.5,P=0.006),但两个队列均保持100%的30天和1年生存率。结论提示在高容量心肺移植中心,即使病情更重、心肺功能快速恶化,仍可获得优异术后结局。
要点
- Era II肺分配评分显著高于Era I(51.1±19.8 vs 41.6±19.5,P=0.006)。
- 两个队列均保持100%的30天和1年生存率。
- 高容量中心对病情更重患者仍可取得优异心肺移植结局。
核心结论
- 在高容量心肺移植项目中,即使患者心肺功能快速严重恶化,仍可获得优异的术后结局,心肺移植仍是晚期心肺疾病患者的可行选择。
研究设计与样本
- 单中心回顾性研究,纳入2008-2018年49例心肺移植受者,比较Era I(2008-2015年,n=30)与Era II(2016-2018年,n=19)两个队列。
主要发现
- 患者人口学特征和等待名单时间随时间无显著变化。
- Era II的肺分配评分显著高于Era I(51.1±19.8 vs 41.6±19.5,P=0.006)。
- Era II术前和术后机械循环支持使用率更高,但差异无统计学意义。
- 尽管当代患者病情更重,仍保持100%的30天和1年生存率。
临床怎么用
- 在高容量心肺移植中心,对病情快速恶化的晚期心肺疾病患者仍可积极评估心肺移植。
- 肺分配评分升高和机械循环支持使用增多时,需关注围术期管理但不应因此排除移植可能。
局限性
- 单中心回顾性设计,样本量有限(共49例),结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Heart-lung transplantation has been established as an effective treatment for patients with advanced cardiopulmonary failure. Over the years, the number of operations performed has declined. In 2015, only 38 adult heart-lung transplants were reported worldwide. Since then, we have performed 16 operations in high-acuity patients with excellent postoperative outcomes. Herein, we review our single-centre experience with heart-lung transplantation over the past 10 years. METHODS: We retrospectively reviewed 49 heart-lung transplant recipients between 2008 and 2018 to investigate the patient characteristics and outcomes while comparing those results across 2 cohorts (2008-2015, Era I, n = 30 and 2016-2018, Era II, n = 19). RESULTS: Our patient demographics and waitlist time did not significantly change over time. However, the lung allocation score was significantly higher in Era II compared to Era I (51.1 ± 19.8 in Era II and 41.6 ± 19.5 in Era I; P = 0.006). We also observed a higher rate-while not statistically significant-of preoperative and postoperative use of mechanical circulatory support in the present era. Although there is a trend of higher acuity in the present era, we continue to have excellent outcomes with 100% 30-day and 1-year survival. CONCLUSIONS: These results suggest that in a high-volume heart-lung transplant programme, excellent postoperative outcomes can be achieved even in patients with rapid and severe cardiopulmonary decline and that, to this day, heart-lung transplantation remains a viable option for patients with advanced cardiopulmonary disease.
引用
- Shudo Y, Kasinpila P, Lingala B, et al. Heart-lung transplantation over the past 10 years: an up-to-date concept. Eur J Cardiothorac Surg. 2019. PMID: 30260389. doi:10.1093/ejcts/ezy253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。